https://stockwhiz.ai/news/safe-harbor-financial-signs-non-binding-term-sheet-to-combine-with-opi-60908b49Stockwhizen2026-10-26T12:24:00.132ZSafe Harbor Financial Signs Non-Binding Term Sheet to Combine with Opifex Media, Creating a Nasdaq-Listed Diversified Holding Companyhttps://stockwhiz.ai/news/strive-announces-1-0-billion-sats-at-the-market-program-1e982e38Stockwhizen2026-10-26T12:16:01.088ZStrive Announces $1.0 Billion SATS At-The-Market Programhttps://stockwhiz.ai/news/nexentis-mitocarex-bio-advances-ai-driven-drug-discovery-initiative-wi-f3c13570Stockwhizen2026-10-26T12:16:00.126ZNexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stagehttps://stockwhiz.ai/news/united-states-antimony-announces-completion-of-new-technical-report-on-107cf1baStockwhizen2026-10-26T12:15:00.992ZUnited States Antimony Announces Completion of New Technical Report on Nolan Creek, Alaska Gold/Antimony Deposithttps://stockwhiz.ai/news/massey-ferguson-introduces-new-singulation-chute-for-mf-sb-1436db-smal-4c75c706Stockwhizen2026-10-26T12:15:00.634ZMassey Ferguson® Introduces New Singulation Chute for MF SB.1436DB Small Square Balerhttps://stockwhiz.ai/news/caci-secures-u-s-navy-task-order-to-strengthen-electromagnetic-spectru-70c4909fStockwhizen2026-10-26T12:15:00.428ZCACI Secures U.S. Navy Task Order to Strengthen Electromagnetic Spectrum Dominancehttps://stockwhiz.ai/news/orafol-fresnel-optics-cuts-inspection-times-in-half-with-zebra-technol-41744e98Stockwhizen2026-10-26T12:10:00.228ZORAFOL Fresnel Optics Cuts Inspection Times in Half with Zebra Technologies’ AI Machine Vision Solutionhttps://stockwhiz.ai/news/oracle-advances-outcome-driven-ai-across-fusion-applications-0c35eb60Stockwhizen2026-10-26T12:09:00.046ZOracle Advances Outcome-Driven AI Across Fusion Applicationshttps://stockwhiz.ai/news/oracle-introduces-ai-agent-ready-fusion-applications-setup-and-configu-521dad3cStockwhizen2026-10-26T12:08:00.251ZOracle Introduces AI Agent-Ready Fusion Applications Setup and Configuration to Speed Implementationshttps://stockwhiz.ai/news/oracle-introduces-claw-powered-fusion-agentic-applications-for-supply--c67ed8d2Stockwhizen2026-10-26T12:07:00.237ZOracle Introduces Claw-Powered Fusion Agentic Applications for Supply Chainhttps://stockwhiz.ai/news/oracle-introduces-claw-powered-fusion-agentic-applications-for-custome-e7e8df21Stockwhizen2026-10-26T12:06:00.028ZOracle Introduces Claw-Powered Fusion Agentic Applications for Customer Experiencehttps://stockwhiz.ai/news/flash-sports-media-holdings-reports-preliminary-unaudited-third-quarte-dcb736b0Stockwhizen2026-10-26T12:05:31.660ZFlash Sports & Media Holdings Reports Preliminary Unaudited Third Quarter Revenue of Approximately $6.2 Million, Driven by Lanka Premier League 2026 Seasonhttps://stockwhiz.ai/news/aptevo-reports-mipletamig-combination-therapy-enabled-21-of-frontline--74e085faStockwhizen2026-10-26T12:05:00.923ZAptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplanthttps://stockwhiz.ai/news/oracle-introduces-new-ai-powered-ways-to-execute-work-across-oracle-fu-86d7c888Stockwhizen2026-10-26T12:05:00.225ZOracle Introduces New AI-Powered Ways to Execute Work Across Oracle Fusion Applicationshttps://stockwhiz.ai/news/medifast-announces-third-quarter-2026-financial-results-ef30f80bStockwhizen2026-10-26T12:05:00.197ZMedifast Announces Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/ameresco-completes-5-9m-advanced-metering-infrastructure-project-for-t-d23abc0dStockwhizen2026-10-26T12:05:00.115ZAmeresco Completes $5.9M Advanced Metering Infrastructure Project for the City of Mustang, Oklahomahttps://stockwhiz.ai/news/avantor-appoints-new-chief-information-officer-0ec0f9b8Stockwhizen2026-10-26T12:05:00.026ZAvantor appoints new Chief Information Officerhttps://stockwhiz.ai/news/oracle-unveils-agentic-ai-platform-to-accelerate-implementation-of-ora-cfb2b7a1Stockwhizen2026-10-26T12:04:00.026ZOracle Unveils Agentic AI Platform to Accelerate Implementation of Oracle Fusion Cloud Applicationshttps://stockwhiz.ai/news/syntec-optics-nasdaq-optx-doubles-production-for-commercial-satellite--dcbac1d4Stockwhizen2026-10-26T12:03:14.084ZSyntec Optics (Nasdaq: OPTX) Doubles Production for Commercial Satellite Laser Optics to Meet Surging Space Demandhttps://stockwhiz.ai/news/oracle-helps-sharkninja-power-up-its-ai-strategy-b242c436Stockwhizen2026-10-26T12:03:00.030ZOracle Helps SharkNinja Power Up Its AI Strategyhttps://stockwhiz.ai/news/wmata-keeps-its-workforce-moving-with-oracle-fusion-applications-4df39a56Stockwhizen2026-10-26T12:02:00.027ZWMATA Keeps Its Workforce Moving with Oracle Fusion Applicationshttps://stockwhiz.ai/news/sierra-bancorp-reports-record-quarterly-income-118736a3Stockwhizen2026-10-26T12:01:00.772ZSierra Bancorp Reports Record Quarterly Incomehttps://stockwhiz.ai/news/acurx-pharmaceuticals-to-discuss-third-quarter-2026-financial-results--16c1bf1fStockwhizen2026-10-26T12:01:00.227ZAcurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Updatehttps://stockwhiz.ai/news/oracle-advances-autonomous-ai-lakehouse-with-business-semantic-layer-a-f219bf02Stockwhizen2026-10-26T12:01:00.024ZOracle Advances Autonomous AI Lakehouse with Business Semantic Layer and Expanded Support for Iceberg Datahttps://stockwhiz.ai/news/invitation-to-the-presentation-of-latour-x27-s-interim-report-for-the--9abda3f5Stockwhizen2026-10-26T12:00:13.433ZInvitation to the presentation of Latour&#x27;s interim report for the third quarter 2026https://stockwhiz.ai/news/boston-scientific-to-participate-in-stifel-x27-s-2026-healthcare-confe-eb009a64Stockwhizen2026-10-26T12:00:10.225ZBoston Scientific to participate in Stifel&#x27;s 2026 Healthcare Conferencehttps://stockwhiz.ai/news/evogene-to-participate-in-upcoming-bio-europe-in-germany-and-drug-disc-89dc3c63Stockwhizen2026-10-26T12:00:09.828ZEvogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spainhttps://stockwhiz.ai/news/first-resource-bancorp-inc-reports-record-third-quarter-2026-financial-2add5572Stockwhizen2026-10-26T12:00:08.907ZFirst Resource Bancorp, Inc. Reports Record Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/fannie-mae-plans-to-report-third-quarter-2026-financial-results-on-oct-48599f0aStockwhizen2026-10-26T12:00:08.629ZFannie Mae Plans to Report Third Quarter 2026 Financial Results on October 28, 2026https://stockwhiz.ai/news/s-p-global-completes-acquisition-of-openzeppelin-202fb4ebStockwhizen2026-10-26T12:00:08.230ZS&P Global Completes Acquisition of OpenZeppelinhttps://stockwhiz.ai/news/burford-announces-date-for-release-of-3q26-financial-results-and-resul-953a2336Stockwhizen2026-10-26T12:00:05.098ZBurford Announces Date for Release of 3Q26 Financial Results and Results Call Registration and Participation Detailshttps://stockwhiz.ai/news/forewarn-introduces-community-alerts-activating-a-nationwide-agent-net-9469767fStockwhizen2026-10-26T12:00:02.407ZFOREWARN Introduces Community Alerts, Activating a Nationwide Agent Network as a Real-Time Safety Resourcehttps://stockwhiz.ai/news/allergan-aesthetics-celebrates-eight-years-of-engaging-girls-in-stem-t-5073c9beStockwhizen2026-10-26T12:00:02.249ZAllergan Aesthetics Celebrates Eight Years of Engaging Girls in STEM Through Continued Partnership with Girls Inc.https://stockwhiz.ai/news/gt-biopharma-selected-for-oral-presentation-at-the-sitc-2026-annual-me-58e0bd86Stockwhizen2026-10-26T12:00:02.171ZGT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meetinghttps://stockwhiz.ai/news/enphase-energy-and-infineon-announce-world-s-first-900-v-gan-bidirecti-76da2d33Stockwhizen2026-10-26T12:00:01.972ZEnphase Energy and Infineon Announce World’s First 900 V GaN Bidirectional Switch Devices for AI Data Center Solid-State Transformershttps://stockwhiz.ai/news/solid-biosciences-announces-european-commission-orphan-designation-for-0d7a2901Stockwhizen2026-10-26T12:00:01.927ZSolid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxiahttps://stockwhiz.ai/news/spero-therapeutics-strengthens-leadership-team-to-advance-immunology-p-8f7b0cdaStockwhizen2026-10-26T12:00:01.885ZSpero Therapeutics Strengthens Leadership Team to Advance Immunology Pipelinehttps://stockwhiz.ai/news/franklin-electric-declares-quarterly-dividend-of-0-28-per-share-59fa9668Stockwhizen2026-10-26T12:00:01.800ZFranklin Electric Declares Quarterly Dividend of $0.28 Per Sharehttps://stockwhiz.ai/news/evernorth-secures-committed-equity-facility-for-approximately-80-milli-f6b7d77dStockwhizen2026-10-26T12:00:01.606ZEvernorth Secures Committed Equity Facility for Approximately $80 Million to Support XRP Treasury Growthhttps://stockwhiz.ai/news/dynex-capital-inc-named-one-of-time-s-america-s-growth-leaders-for-202-aae469e0Stockwhizen2026-10-26T12:00:01.569ZDynex Capital, Inc. Named One of TIME’s America’s Growth Leaders for 2027https://stockwhiz.ai/news/sealsq-announces-intent-to-acquire-capacity-and-operational-services-a-3e07ac89Stockwhizen2026-10-26T12:00:01.568ZSEALSQ Announces Intent to Acquire Capacity and Operational Services Associated with 12 WISeSat.Space Satellites for QSOChttps://stockwhiz.ai/news/vyome-co-founder-dr-shiladitya-sengupta-promoted-to-professor-at-harva-f095abb8Stockwhizen2026-10-26T12:00:01.537ZVyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical Schoolhttps://stockwhiz.ai/news/kratos-defense-security-solutions-schedules-third-quarter-2026-earning-fab5b6b5Stockwhizen2026-10-26T12:00:01.517ZKratos Defense & Security Solutions Schedules Third Quarter 2026 Earnings Conference Call for Thursday, November 5thhttps://stockwhiz.ai/news/archer-to-report-third-quarter-2026-operating-update-and-financial-res-2f4a19d7Stockwhizen2026-10-26T12:00:01.508ZArcher To Report Third Quarter 2026 Operating Update and Financial Results on November 9th, 2026https://stockwhiz.ai/news/gamesquare-closes-fanengine-transaction-24b670d7Stockwhizen2026-10-26T12:00:01.472ZGameSquare Closes FanEngine Transactionhttps://stockwhiz.ai/news/corcept-reports-positive-results-from-phase-2-bella-trial-of-lifyorli--b51da144Stockwhizen2026-10-26T12:00:01.456ZCorcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancerhttps://stockwhiz.ai/news/gigcapital9-announces-letter-of-intent-for-proposed-business-combinati-61e33effStockwhizen2026-10-26T12:00:01.423ZGigCapital9 Announces Letter of Intent for Proposed Business Combination with a Leading Clean Energy Technology Companyhttps://stockwhiz.ai/news/estrella-immunopharma-appoints-cynthia-pussinen-as-chief-executive-off-7da89bb0Stockwhizen2026-10-26T12:00:01.395ZEstrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board of Directorshttps://stockwhiz.ai/news/mubadala-capital-announces-strategic-investment-from-apollo-722fa481Stockwhizen2026-10-26T12:00:01.242ZMubadala Capital Announces Strategic Investment from Apollohttps://stockwhiz.ai/news/stem-announces-review-of-strategic-alternatives-to-maximize-shareholde-8eb79476Stockwhizen2026-10-26T12:00:01.190ZStem Announces Review of Strategic Alternatives to Maximize Shareholder Valuehttps://stockwhiz.ai/news/solid-power-announces-significant-advancement-in-commercial-pathway-co-f26fb2faStockwhizen2026-10-26T12:00:01.169ZSolid Power Announces Significant Advancement in Commercial Pathway, Commissioning MOBIUS™ Continuous Electrolyte Manufacturing Linehttps://stockwhiz.ai/news/mirum-pharmaceuticals-announces-positive-results-from-cohort-2-of-the--e13e9da8Stockwhizen2026-10-26T12:00:01.148ZMirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans Progressivahttps://stockwhiz.ai/news/iambic-presents-updated-iam1363-clinical-data-at-esmo-2026-showing-dur-25476ac5Stockwhizen2026-10-26T12:00:01.111ZIambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancershttps://stockwhiz.ai/news/comscore-to-announce-third-quarter-2026-financial-results-1f7d8f68Stockwhizen2026-10-26T12:00:01.095ZComscore to Announce Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/optimi-health-establishes-optimi-australia-pty-ltd-as-dedicated-distri-c9496882Stockwhizen2026-10-26T12:00:01.031ZOptimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entityhttps://stockwhiz.ai/news/oracle-announces-deep-trust-ai-architecture-to-help-enterprises-innova-9edb143cStockwhizen2026-10-26T12:00:01.028ZOracle Announces Deep Trust AI Architecture to Help Enterprises Innovate with Confidencehttps://stockwhiz.ai/news/twist-bioscience-to-report-fiscal-2026-fourth-quarter-and-full-year-fi-52a28215Stockwhizen2026-10-26T12:00:00.949ZTwist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026https://stockwhiz.ai/news/certara-to-report-third-quarter-2026-financial-results-on-november-5th-971363e1Stockwhizen2026-10-26T12:00:00.911ZCertara to Report Third Quarter 2026 Financial Results on November 5th, 2026https://stockwhiz.ai/news/btcs-inc-commences-modified-dutch-auction-cash-tender-offer-for-its-se-d2696406Stockwhizen2026-10-26T12:00:00.881ZBTCS Inc. Commences Modified Dutch Auction Cash Tender Offer for Its Series V Preferred Stock at $0.04 to $1.00 per Sharehttps://stockwhiz.ai/news/walmart-expands-better-care-services-powered-by-general-medicine-s-hea-5eb8b156Stockwhizen2026-10-26T12:00:00.873ZWalmart Expands Better Care Services, Powered by General Medicine’s Healthcare Storehttps://stockwhiz.ai/news/biovie-invited-to-present-data-on-bezisterim-in-long-covid-at-the-nih--94bfc626Stockwhizen2026-10-26T12:00:00.821ZBioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshophttps://stockwhiz.ai/news/hadron-energy-strengthens-halo-reactor-engineering-team-with-three-sen-a62e85e0Stockwhizen2026-10-26T12:00:00.779ZHadron Energy Strengthens Halo Reactor Engineering Team with Three Senior Component Design and Analysis Leadershttps://stockwhiz.ai/news/valion-bio-receives-unsolicited-acquisition-interest-in-velocity-biowo-3b2b836cStockwhizen2026-10-26T12:00:00.713ZValion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Optionshttps://stockwhiz.ai/news/amwell-to-report-third-quarter-2026-operating-results-5c7209c7Stockwhizen2026-10-26T12:00:00.637ZAmwell® to report third quarter 2026 operating resultshttps://stockwhiz.ai/news/adial-pharmaceuticals-announces-planned-appointment-of-celia-economide-ebd41052Stockwhizen2026-10-26T12:00:00.531ZAdial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officerhttps://stockwhiz.ai/news/coincheck-group-n-v-to-announce-second-quarter-2027-financial-results--93b0b5d8Stockwhizen2026-10-26T12:00:00.495ZCoincheck Group N.V. to Announce Second Quarter 2027 Financial Results on November 9, 2026https://stockwhiz.ai/news/c-h-robinson-debuts-lean-ai-for-ocean-shipping-air-freight-and-customs-6f75e497Stockwhizen2026-10-26T12:00:00.468ZC.H. Robinson Debuts Lean AI for Ocean Shipping, Air Freight and Customshttps://stockwhiz.ai/news/stryker-completes-acquisition-of-zurimed-to-enhance-its-shoulder-offer-f975dd29Stockwhizen2026-10-26T12:00:00.453ZStryker completes acquisition of ZuriMED to enhance its shoulder offeringhttps://stockwhiz.ai/news/renx-enterprises-issues-letter-to-shareholders-c5112eefStockwhizen2026-10-26T12:00:00.446ZRenX Enterprises Issues Letter to Shareholdershttps://stockwhiz.ai/news/defi-development-corp-adds-5-346-sol-as-solana-s-alpenglow-upgrade-goe-576afb8dStockwhizen2026-10-26T12:00:00.369ZDeFi Development Corp. Adds 5,346 SOL as Solana’s Alpenglow Upgrade Goes Livehttps://stockwhiz.ai/news/atricure-to-participate-at-upcoming-investor-conferences-fadfd86aStockwhizen2026-10-26T12:00:00.327ZAtriCure to Participate at Upcoming Investor Conferenceshttps://stockwhiz.ai/news/shark-beauty-launches-limited-edition-cryoglow-led-mask-color-co-desig-00bf72a8Stockwhizen2026-10-26T12:00:00.313ZShark Beauty Launches Limited-Edition CryoGlow LED Mask Color, Co-Designed with Kevin Harthttps://stockwhiz.ai/news/senseonics-initiates-first-in-human-study-of-freedom-designed-to-be-th-1d658628Stockwhizen2026-10-26T12:00:00.291ZSenseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Componenthttps://stockwhiz.ai/news/transcon-pth-palopegteriparatide-demonstrates-sustained-clinically-mea-202d7a90Stockwhizen2026-10-26T12:00:00.244ZTransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Yearshttps://stockwhiz.ai/news/amaero-announces-date-of-third-quarter-2026-earnings-release-and-confe-656d907cStockwhizen2026-10-26T12:00:00.199ZAmaero Announces Date of Third Quarter 2026 Earnings Release and Conference Callhttps://stockwhiz.ai/news/gabelli-to-host-8th-annual-healthcare-symposium-e252f6f9Stockwhizen2026-10-26T12:00:00.165ZGabelli To Host 8th Annual Healthcare Symposiumhttps://stockwhiz.ai/news/tcim-provides-update-on-voya-s-effort-to-prevent-the-voices-of-shareho-d372b796Stockwhizen2026-10-26T12:00:00.112ZTCIM Provides Update on Voya’s Effort to Prevent the Voices of Shareholders from Being Heardhttps://stockwhiz.ai/news/wisesat-space-announces-sealsq-s-firm-intent-to-acquire-capacity-and-o-93a24688Stockwhizen2026-10-26T12:00:00.060ZWISeSat.Space Announces SEALSQ’s Firm Intent to Acquire Capacity and Operational Services Associated with 12 Satellites for QSOChttps://stockwhiz.ai/analyst-ratings/paypal-holdings-inc-clear-street-hold-pt-60-df9d4726Stockwhizen2026-10-26T11:58:49.360ZClear Street maintains Hold on PayPal Holdings Inc., raises price target to 60 from 55https://stockwhiz.ai/analyst-ratings/nvidia-corporation-bernstein-buy-pt-400-21ba99c7Stockwhizen2026-10-26T11:56:50.431ZBernstein maintains Buy on NVIDIA Corporation, maintains PT at $400https://stockwhiz.ai/analyst-ratings/advanced-micro-devices-inc-bernstein-buy-pt-650-ce8c283cStockwhizen2026-10-26T11:56:17.402ZBernstein maintains Buy on AMD, maintains PT at $650https://stockwhiz.ai/news/artelo-biosciences-to-showcase-first-in-human-fabp5-inhibitor-art26-12-4df668a8Stockwhizen2026-10-26T11:55:00.130ZArtelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Painhttps://stockwhiz.ai/analyst-ratings/broadcom-inc-bernstein-buy-pt-575-acb8bd86Stockwhizen2026-10-26T11:54:52.025ZBernstein maintains Buy on Broadcom, maintains PT at $575https://stockwhiz.ai/analyst-ratings/dell-technologies-inc-bernstein-buy-pt-650-2b69c7b0Stockwhizen2026-10-26T11:54:19.772ZBernstein maintains Buy on Dell Technologies, maintains PT at $650https://stockwhiz.ai/analyst-ratings/applied-materials-inc-bernstein-buy-pt-700-1cc9291dStockwhizen2026-10-26T11:53:56.378ZBernstein maintains Buy on Applied Materials, maintains PT at $700https://stockwhiz.ai/analyst-ratings/sandisk-corporation-bernstein-buy-pt-3000-8f27fce0Stockwhizen2026-10-26T11:53:27.960ZBernstein maintains Buy on SanDisk, maintains PT at $3000https://stockwhiz.ai/news/chipotle-to-bring-back-mesquite-smoked-brisket-for-the-heart-of-footba-cdff0a48Stockwhizen2026-10-26T11:53:00.026ZCHIPOTLE TO BRING BACK MESQUITE-SMOKED BRISKET FOR THE HEART OF FOOTBALL SEASONhttps://stockwhiz.ai/analyst-ratings/super-micro-computer-inc-bernstein-hold-pt-42-5b07c120Stockwhizen2026-10-26T11:52:48.975ZBernstein maintains Hold on Super Micro Computer, maintains PT at $42https://stockwhiz.ai/analyst-ratings/sarepta-therapeutics-inc-wedbush-buy-pt-35-3585ab39Stockwhizen2026-10-26T11:52:28.527ZWedbush maintains Buy on Sarepta Therapeutics; maintains PT at $35https://stockwhiz.ai/analyst-ratings/western-digital-corporation-bernstein-buy-pt-600-b78363aaStockwhizen2026-10-26T11:51:39.535ZBernstein maintains Buy on Western Digital Corporation, cuts PT to $600 from $770https://stockwhiz.ai/analyst-ratings/microsoft-corporation-scotiabank-sector-outperform-pt-625-dc4e73a9Stockwhizen2026-10-26T11:45:23.735ZScotiabank maintains Sector Outperform on Microsoft Corporation, raises PT to $625 from $615https://stockwhiz.ai/analyst-ratings/sofi-technologies-inc-monness-crespi-hardt-buy-pt-20-e0d0abafStockwhizen2026-10-26T11:42:18.304ZMonness, Crespi, Hardt initiates Buy on SoFi Technologies, PT $20https://stockwhiz.ai/analyst-ratings/nu-holdings-ltd-monness-crespi-hardt-buy-pt-20-1cba0ce7Stockwhizen2026-10-26T11:41:42.082ZMonness, Crespi, Hardt initiates Buy on Nu Holdings, PT $20https://stockwhiz.ai/analyst-ratings/affirm-holdings-inc-monness-crespi-hardt-buy-pt-90-32ce65b8Stockwhizen2026-10-26T11:40:59.108ZMonness, Crespi, Hardt initiates Buy on Affirm Holdings, PT $90https://stockwhiz.ai/analyst-ratings/moderna-inc-piper-sandler-overweight-pt-230-221d4ab3Stockwhizen2026-10-26T11:39:51.231ZPiper Sandler maintains Overweight on Moderna, raises PT to $230 from $167https://stockwhiz.ai/news/22nd-century-expands-the-pinnacle-pure-portfolio-to-6-sku-s-with-addit-9659581aStockwhizen2026-10-26T11:37:00.098Z22nd Century Expands the Pinnacle Pure Portfolio To 6 SKU’s With Addition of 100’s and Menthol Varietieshttps://stockwhiz.ai/analyst-ratings/terawulf-inc-cantor-fitzgerald-overweight-pt-30-e8bee8cdStockwhizen2026-10-26T11:35:39.603ZCantor Fitzgerald reiterates Overweight on TeraWulf Inc., PT $30https://stockwhiz.ai/analyst-ratings/coreweave-inc-cantor-fitzgerald-overweight-pt-176-4db2c870Stockwhizen2026-10-26T11:35:00.441ZCantor Fitzgerald reiterates Overweight on CoreWeave, PT $176https://stockwhiz.ai/news/venhub-and-follett-higher-education-form-strategic-partnership-to-expa-3ae12ad8Stockwhizen2026-10-26T11:35:00.111ZVenHub and Follett Higher Education Form Strategic Partnership to Expand 24/7 Autonomous Retail Across College and University Campuseshttps://stockwhiz.ai/analyst-ratings/intel-corporation-rbc-capital-sector-perform-pt-100-af4ffd5bStockwhizen2026-10-26T11:34:19.604ZRBC Capital reiterates Sector Perform on Intel, PT $100https://stockwhiz.ai/analyst-ratings/block-inc-morgan-stanley-equalweight-pt-80-c2bc43f8Stockwhizen2026-10-26T11:33:22.346ZMorgan Stanley downgrades Block, Inc. from Overweight to Equalweight, cuts PT to $80 from $90https://stockwhiz.ai/news/transcode-therapeutics-presents-phase-1a-clinical-data-for-ttx-mc138-a-56c4ca2fStockwhizen2026-10-26T11:31:00.225ZTransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026https://stockwhiz.ai/news/soluna-completes-full-repayment-of-generate-capital-debt-952c267dStockwhizen2026-10-26T11:30:02.074ZSoluna Completes Full Repayment of Generate Capital Debthttps://stockwhiz.ai/news/arthritis-foundation-and-founding-sponsor-zimmer-biomet-announce-new-c-31b7a9f7Stockwhizen2026-10-26T11:30:02.039ZArthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint Painhttps://stockwhiz.ai/news/biohaven-oral-presentation-at-asn-kidney-week-2026-spotlights-bhv-1420-09aa92c5Stockwhizen2026-10-26T11:30:01.635ZBiohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathyhttps://stockwhiz.ai/news/powerbank-strengthens-balance-sheet-and-solar-portfolio-with-14-reduct-5742cfabStockwhizen2026-10-26T11:30:01.434ZPowerBank Strengthens Balance Sheet and Solar Portfolio with 14% Reduction in Project Debt with Completion of CA$25.4M Refinancinghttps://stockwhiz.ai/news/kingsway-to-report-financial-results-for-third-quarter-2026-on-thursda-2e73ce60Stockwhizen2026-10-26T11:30:01.104ZKingsway To Report Financial Results For Third Quarter 2026 on Thursday, November 5, 2026https://stockwhiz.ai/news/tuhura-biosciences-provides-first-look-at-data-from-its-open-label-stu-4f313fe1Stockwhizen2026-10-26T11:30:00.831ZTuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line Treatment of Patients with Deep Seated Metastatic Merkel Cell Carcinomahttps://stockwhiz.ai/news/city-holding-company-announces-record-quarterly-results-682f0822Stockwhizen2026-10-26T11:30:00.748ZCity Holding Company Announces Record Quarterly Resultshttps://stockwhiz.ai/news/davion-healthcare-announces-us-25-million-acquisition-of-humaskan-medi-8042bc10Stockwhizen2026-10-26T11:30:00.622ZDavion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IPhttps://stockwhiz.ai/news/quantum-cyber-invited-to-present-quantum-antenna-technology-at-quantum-ec959e57Stockwhizen2026-10-26T11:30:00.588ZQuantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Conveninghttps://stockwhiz.ai/news/cae-to-sell-flightscape-to-sita-465c0e64Stockwhizen2026-10-26T11:30:00.426ZCAE to sell Flightscape to SITAhttps://stockwhiz.ai/news/ast-spacemobile-advances-brazil-expansion-with-anatel-s-approval-for-s-4777d799Stockwhizen2026-10-26T11:30:00.422ZAST SpaceMobile Advances Brazil Expansion with Anatel’s Approval for S-band Spectrum and Secondary Use of the 700 MHz Band, Agreements with Four Regional Operators and Planned Ground Infrastructurehttps://stockwhiz.ai/news/canopy-growth-announces-results-of-2026-annual-general-and-special-mee-12bc260cStockwhizen2026-10-26T11:30:00.334ZCanopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholdershttps://stockwhiz.ai/news/immuneering-presents-design-and-methodology-of-ongoing-phase-3-mapkeep-c7fdb8eaStockwhizen2026-10-26T11:30:00.307ZImmuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026https://stockwhiz.ai/news/turning-point-brands-to-host-q3-2026-conference-call-807fc4aaStockwhizen2026-10-26T11:30:00.245ZTurning Point Brands to Host Q3 2026 Conference Callhttps://stockwhiz.ai/news/xilio-therapeutics-announces-first-patient-dosed-in-phase-1-2-clinical-e6ebb526Stockwhizen2026-10-26T11:30:00.241ZXilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLChttps://stockwhiz.ai/news/camping-world-holdings-inc-to-announce-third-quarter-2026-earnings-on--517a8e9cStockwhizen2026-10-26T11:30:00.210ZCamping World Holdings, Inc. to Announce Third Quarter 2026 Earnings on November 2, 2026, with a Call Premarket on November 3, 2026https://stockwhiz.ai/news/medicus-pharma-regains-compliance-with-nasdaq-minimum-bid-price-requir-140b2292Stockwhizen2026-10-26T11:30:00.184ZMedicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirementhttps://stockwhiz.ai/news/napco-security-technologies-to-announce-fiscal-first-quarter-2027-resu-5479ff80Stockwhizen2026-10-26T11:30:00.023ZNAPCO Security Technologies to Announce Fiscal First Quarter 2027 Results Monday, November 2, 2026https://stockwhiz.ai/analyst-ratings/oracle-corporation-wells-fargo-overweight-pt-250-be994d37Stockwhizen2026-10-26T11:29:30.061ZWells Fargo maintains Overweight on Oracle Corporation, cuts PT to $250 from $280https://stockwhiz.ai/analyst-ratings/bloom-energy-corp-evercore-isi-outperform-pt-350-5df62504Stockwhizen2026-10-26T11:28:25.052ZEvercore ISI reiterates Outperform on Bloom Energy Corp., PT $350https://stockwhiz.ai/analyst-ratings/rocket-lab-corporation-cantor-fitzgerald-overweight-pt-122-67314022Stockwhizen2026-10-26T11:27:43.411ZCantor Fitzgerald reiterates Overweight on Rocket Lab Corporation, PT $122https://stockwhiz.ai/analyst-ratings/galaxy-digital-inc-rosenblatt-buy-pt-30-7bae2672Stockwhizen2026-10-26T11:26:44.456ZRosenblatt maintains Buy on Galaxy Digital, cuts PT to $30 from $35https://stockwhiz.ai/analyst-ratings/oracle-corporation-mizuho-outperform-pt-320-b6b784e0Stockwhizen2026-10-26T11:19:59.653ZMizuho reiterates Outperform on Oracle Corporation, PT $320https://stockwhiz.ai/analyst-ratings/tempus-ai-inc-h-c-wainwright-buy-pt-68-8fa666d4Stockwhizen2026-10-26T11:19:13.038ZH.C. Wainwright maintains Buy on Tempus AI Inc., raises PT to $68 from $66https://stockwhiz.ai/analyst-ratings/nxp-semiconductors-n-v-cantor-fitzgerald-overweight-pt-400-8c5fb0b9Stockwhizen2026-10-26T11:18:27.544ZCantor Fitzgerald reiterates Overweight on NXP Semiconductors, PT $400https://stockwhiz.ai/news/reg-natixis-form-8-3-prologis-inc-b3351693Stockwhizen2026-10-26T11:18:00.123ZREG-NATIXIS Form 8.3 Prologis, Inchttps://stockwhiz.ai/news/dot-ai-appoints-technology-industry-veteran-avi-cohen-to-board-of-dire-082ca78eStockwhizen2026-10-26T11:17:00.118ZDot Ai Appoints Technology Industry Veteran Avi Cohen to Board of Directorshttps://stockwhiz.ai/news/macrogenics-announces-positive-interim-phase-2-linnet-results-for-lori-5483eb0bStockwhizen2026-10-26T11:06:11.109ZMacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancerhttps://stockwhiz.ai/analyst-ratings/coherent-corp-stonex-buy-pt-425-5ebc4bd5Stockwhizen2026-10-26T11:05:14.621ZStoneX initiates coverage of Coherent Corp. with Buy rating and $425 price targethttps://stockwhiz.ai/news/hbt-financial-inc-announces-third-quarter-2026-financial-results-b265a9e5Stockwhizen2026-10-26T11:05:01.055ZHBT Financial, Inc. Announces Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/metropolitan-commercial-bank-earns-great-place-to-work-certification-f-e6a2c74fStockwhizen2026-10-26T11:05:00.144ZMetropolitan Commercial Bank Earns Great Place To Work® Certification™ for Second Consecutive Yearhttps://stockwhiz.ai/news/cyngn-completes-inaugural-soc-2-type-ii-examination-with-zero-exceptio-63c8f1a0Stockwhizen2026-10-26T11:05:00.027ZCyngn Completes Inaugural SOC 2 Type II Examination with Zero Exceptions, Launches Enterprise Trust Centerhttps://stockwhiz.ai/analyst-ratings/lumentum-holdings-inc-stonex-buy-pt-1200-684e9f7fStockwhizen2026-10-26T11:02:57.573ZStoneX initiates coverage on Lumentum with Buy rating and $1,200 price targethttps://stockwhiz.ai/news/arko-corp-to-report-third-quarter-2026-financial-results-on-november-5-12217f98Stockwhizen2026-10-26T11:01:00.114ZARKO Corp. to Report Third Quarter 2026 Financial Results on November 5, 2026https://stockwhiz.ai/news/aetna-provider-survey-shows-payer-provider-trust-remains-strong-provid-56d92037Stockwhizen2026-10-26T11:00:08.027ZAetna Provider Survey Shows Payer-Provider Trust Remains Strong; Providers say Reducing Fraud can Significantly Lower Health Care Costshttps://stockwhiz.ai/news/lakeland-financial-reports-record-third-quarter-performance-with-loan--a6d52f4eStockwhizen2026-10-26T11:00:05.279ZLakeland Financial Reports Record Third Quarter Performance with Loan Growth of 8%; Diluted Earnings per Share Increases by 11%https://stockwhiz.ai/news/healthcare-triangle-enters-neurotechnology-ai-devices-and-solutions-fo-4f2071ceStockwhizen2026-10-26T11:00:05.236ZHealthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asiahttps://stockwhiz.ai/news/oruka-therapeutics-announces-positive-week-16-results-for-orka-001-fro-976ecc65Stockwhizen2026-10-26T11:00:03.781ZOruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasishttps://stockwhiz.ai/news/nayax-to-report-2026-q3-earnings-on-november-11-2026-a9d5fde1Stockwhizen2026-10-26T11:00:03.673ZNayax to Report 2026 Q3 Earnings on November 11, 2026https://stockwhiz.ai/news/iovance-announces-data-showing-durable-responses-with-lifileucel-til-c-1b083f92Stockwhizen2026-10-26T11:00:03.453ZIovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026https://stockwhiz.ai/news/regeneron-extends-agreement-with-barda-to-provide-additional-supply-of-195a2574Stockwhizen2026-10-26T11:00:03.347ZRegeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparednesshttps://stockwhiz.ai/news/arko-petroleum-corp-to-report-third-quarter-2026-financial-results-on--7112b73eStockwhizen2026-10-26T11:00:03.109ZARKO Petroleum Corp. to Report Third Quarter 2026 Financial Results on November 4, 2026https://stockwhiz.ai/news/harrow-to-report-third-quarter-2026-financial-results-after-market-clo-9167ebc0Stockwhizen2026-10-26T11:00:02.762ZHarrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026https://stockwhiz.ai/news/highpeak-energy-inc-announces-2026-third-quarter-earnings-release-and--3cf12a2bStockwhizen2026-10-26T11:00:02.574ZHighPeak Energy, Inc. Announces 2026 Third Quarter Earnings Release and Conference Call Dateshttps://stockwhiz.ai/news/eledon-pharmaceuticals-presents-phase-2-bestow-trial-data-showing-sust-a4fd4d9dStockwhizen2026-10-26T11:00:02.525ZEledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meetinghttps://stockwhiz.ai/earning-releases/vz-q3-2026-earnings-6cf90ffcStockwhizen2026-10-26T11:00:02.175ZVerizon Communications Inc. (VZ) Non-GAAP EPS of $1.31 beats by $0.04, revenue of $34.31B misses by $537M.https://stockwhiz.ai/news/verizon-delivers-another-record-breaking-quarter-with-3q-2026-results--6c1421a0Stockwhizen2026-10-26T11:00:02.175ZVerizon Delivers Another Record-Breaking Quarter with 3Q 2026 Results Driven by Strong Postpaid Phone and Account Additionshttps://stockwhiz.ai/news/compugen-to-release-third-quarter-2026-results-on-monday-november-9-20-e4dd950cStockwhizen2026-10-26T11:00:01.841ZCompugen to Release Third Quarter 2026 Results on Monday, November 9, 2026https://stockwhiz.ai/news/denarius-metals-announces-further-ramp-up-in-its-third-quarter-and-fir-860e6329Stockwhizen2026-10-26T11:00:01.641ZDENARIUS METALS ANNOUNCES FURTHER RAMP UP IN ITS THIRD QUARTER AND FIRST NINE MONTHS 2026 PRODUCTION RESULTS FROM ITS ZANCUDO PROJECT IN COLOMBIAhttps://stockwhiz.ai/news/turo-and-tesla-debut-industry-first-self-driving-rental-experience-305a8006Stockwhizen2026-10-26T11:00:01.512ZTuro and Tesla Debut Industry-First Self-Driving Rental Experiencehttps://stockwhiz.ai/news/acumen-pharmaceuticals-reports-third-quarter-2026-financial-results-an-8338566bStockwhizen2026-10-26T11:00:01.283ZAcumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlightshttps://stockwhiz.ai/news/fate-therapeutics-presents-updated-preliminary-data-for-ft819-in-activ-bdafd373Stockwhizen2026-10-26T11:00:01.019ZFate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026https://stockwhiz.ai/news/autozone-chief-financial-officer-jamere-jackson-to-depart-november-25--98088b1fStockwhizen2026-10-26T11:00:00.934ZAutoZone Chief Financial Officer Jamere Jackson to Depart November 25, 2026https://stockwhiz.ai/news/syndax-to-announce-third-quarter-2026-financial-results-and-host-confe-6ab7f5adStockwhizen2026-10-26T11:00:00.848ZSyndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026https://stockwhiz.ai/news/first-farmers-and-merchants-corporation-reports-third-quarter-net-inco-e73dfde4Stockwhizen2026-10-26T11:00:00.823ZFirst Farmers and Merchants Corporation Reports Third Quarter Net Income Up 12.7% to $5.5 Millionhttps://stockwhiz.ai/news/fedex-names-jamere-jackson-as-executive-vice-president-and-chief-finan-635523ccStockwhizen2026-10-26T11:00:00.778ZFedEx Names Jamere Jackson as Executive Vice President and Chief Financial Officerhttps://stockwhiz.ai/news/alliance-resource-partners-l-p-reports-third-quarter-2026-financial-an-e81d31abStockwhizen2026-10-26T11:00:00.760ZAlliance Resource Partners, L.P. Reports Third Quarter 2026 Financial and Operating Results; Declares Quarterly Cash Distribution of $0.60 Per Unit; and Updates Guidancehttps://stockwhiz.ai/news/braemar-unveils-highly-qualified-independent-board-slate-for-company-s-dc8f91aeStockwhizen2026-10-26T11:00:00.741ZBraemar Unveils Highly Qualified Independent Board Slate for Company’s New Chapterhttps://stockwhiz.ai/news/jack-in-the-box-announces-fourth-quarter-and-full-year-2026-earnings-w-c2e57676Stockwhizen2026-10-26T11:00:00.660ZJack in the Box Announces Fourth Quarter and Full-Year 2026 Earnings Webcasthttps://stockwhiz.ai/news/walmart-unwraps-three-major-holiday-shopping-events-bringing-big-savin-e135278dStockwhizen2026-10-26T11:00:00.656ZWalmart Unwraps Three Major Holiday Shopping Events, Bringing Big Savings on Gifts and Seasonal Favoriteshttps://stockwhiz.ai/news/enanta-pharmaceuticals-announces-first-patient-dosed-in-the-resolve-ph-495b12cdStockwhizen2026-10-26T11:00:00.638ZEnanta Pharmaceuticals Announces First Patient Dosed in the RESOLVE Phase 2b/3 Study of Zelicapavir, a Potential First-in-Disease Treatment for Respiratory Syncytial Virus (RSV)https://stockwhiz.ai/news/genius-sports-to-announce-third-quarter-2026-results-on-november-5-3436ba1aStockwhizen2026-10-26T11:00:00.605ZGenius Sports to Announce Third Quarter 2026 Results on November 5https://stockwhiz.ai/news/natera-shares-real-world-analyses-and-data-at-asn-kidney-week-2026-hig-fc6a3f99Stockwhizen2026-10-26T11:00:00.573ZNatera Shares Real-World Analyses and Data at ASN Kidney Week 2026, Highlighting the Critical Need for Genetic Testing with Renasight™https://stockwhiz.ai/news/origin-agritech-x27-s-three-new-corn-varieties-pass-preliminary-nation-4d191e40Stockwhizen2026-10-26T11:00:00.557ZOrigin Agritech&#x27;s Three New Corn Varieties Pass Preliminary National Review, Advancing Toward Commercializationhttps://stockwhiz.ai/news/gxo-and-agility-robotics-expand-partnership-to-accelerate-deployment-o-b1e48c74Stockwhizen2026-10-26T11:00:00.546ZGXO and Agility Robotics Expand Partnership to Accelerate Deployment of Humanoids in U.S. Operationshttps://stockwhiz.ai/news/electra-refinery-construction-remains-on-budget-as-workforce-doubles-4899a589Stockwhizen2026-10-26T11:00:00.523ZElectra Refinery Construction Remains on Budget as Workforce Doubleshttps://stockwhiz.ai/news/genmab-announces-updated-phase-2-data-demonstrating-more-than-two-year-63b50a73Stockwhizen2026-10-26T11:00:00.469ZGenmab Announces Updated Phase 2 Data Demonstrating More Than Two-Year Median Overall Survival with Petosemtamab Plus Pembrolizumab in First-Line Recurrent/Metastatic Head and Neck Squamous Cell Carcinomahttps://stockwhiz.ai/news/tonix-pharmaceuticals-to-report-third-quarter-2026-financial-results-o-0b6fecbdStockwhizen2026-10-26T11:00:00.445ZTonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026https://stockwhiz.ai/news/immunome-presents-additional-clinical-data-for-varegacestat-in-desmoid-79d53bc3Stockwhizen2026-10-26T11:00:00.280ZImmunome Presents Additional Clinical Data for Varegacestat in Desmoid Tumors at ESMO 2026https://stockwhiz.ai/news/d-wave-quantum-to-participate-in-upcoming-investor-conferences-fa34f6e2Stockwhizen2026-10-26T11:00:00.196ZD-Wave Quantum to Participate in Upcoming Investor Conferenceshttps://stockwhiz.ai/news/builders-firstsource-annual-charity-event-raises-1-6-million-for-blood-bd986a45Stockwhizen2026-10-26T11:00:00.145ZBuilders FirstSource Annual Charity Event Raises $1.6 Million for Blood Cancer Unitedhttps://stockwhiz.ai/news/reg-genmab-announces-updated-phase-2-data-demonstrating-more-than-two--cffd6a26Stockwhizen2026-10-26T11:00:00.102ZREG-Genmab Announces Updated Phase 2 Data Demonstrating More Than Two-Year Median Overall Survival with Petosemtamab Plus Pembrolizumab in First-Line Recurrent/Metastatic Head and Neck Squamous Cell Carcinomahttps://stockwhiz.ai/news/meta-announces-launch-of-offering-of-depositary-shares-representing-se-faee3b8cStockwhizen2026-10-26T10:58:14.114ZMeta Announces Launch of Offering of Depositary Shares Representing Series A Mandatory Convertible Preferred Stock and Offering of Class A Common Stock in Connection with Forward Sale Agreementshttps://stockwhiz.ai/news/valor-energy-inc-announces-us-5-0-million-private-placement-to-support-f499b808Stockwhizen2026-10-26T10:58:00.205ZValor Energy Inc. Announces US$5.0 Million Private Placement to Support Planned AI Data Center Developmenthttps://stockwhiz.ai/news/aecom-announces-planned-dates-for-fourth-quarter-and-full-year-fiscal--a45c63b4Stockwhizen2026-10-26T10:55:00.127ZAECOM announces planned dates for fourth quarter and full year fiscal 2026 earnings results and conference callhttps://stockwhiz.ai/analyst-ratings/microsoft-corporation-oppenheimer-outperform-pt-625-7ab45137Stockwhizen2026-10-26T10:53:14.624ZOppenheimer maintains Outperform on Microsoft, raises PT to $625 from $570 ahead of F1Q resultshttps://stockwhiz.ai/analyst-ratings/micron-technology-inc-bofa-securities-buy-pt-1550-f461ef9bStockwhizen2026-10-26T10:47:53.501ZBofA Securities maintains Buy on Micron Technology, maintains PT at $1,550https://stockwhiz.ai/analyst-ratings/amazon-com-inc-ubs-buy-pt-348-882379f4Stockwhizen2026-10-26T10:45:34.862ZUBS maintains Buy on Amazon.com, raises PT to $348 from $318https://stockwhiz.ai/news/bank-of-hawai-i-corporation-third-quarter-2026-financial-results-cdd753c3Stockwhizen2026-10-26T10:45:00.749ZBank of Hawai‘i Corporation Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/brightstar-lottery-x27-s-cash-pop-game-launched-in-canada-with-the-ont-1938cc04Stockwhizen2026-10-26T10:45:00.424ZBrightstar Lottery&#x27;s Cash Pop Game Launched in Canada with the Ontario Lottery and Gaming Corporationhttps://stockwhiz.ai/news/ovintiv-announces-agreement-to-acquire-montney-oil-producer-logan-ener-1b6fa679Stockwhizen2026-10-26T10:45:00.229ZOvintiv Announces Agreement to Acquire Montney Oil Producer, Logan Energy Corp.https://stockwhiz.ai/news/ferguson-to-issue-third-quarter-results-and-host-conference-call-on-no-4905b0f7Stockwhizen2026-10-26T10:45:00.187ZFerguson to Issue Third Quarter Results And Host Conference Call on November 9, 2026https://stockwhiz.ai/news/jacobs-to-hold-its-fiscal-fourth-quarter-and-full-year-2026-earnings-c-8129c2f1Stockwhizen2026-10-26T10:45:00.143ZJacobs to hold its fiscal fourth quarter and full year 2026 earnings conference call and webcasthttps://stockwhiz.ai/analyst-ratings/fair-isaac-corproation-wells-fargo-equal-weight-pt-735-f3ee5679Stockwhizen2026-10-26T10:43:49.042ZWells Fargo downgrades Fair Isaac from Overweight to Equal Weight, cuts PT to $735 from $800https://stockwhiz.ai/analyst-ratings/reddit-inc-truist-securities-buy-pt-275-3732223dStockwhizen2026-10-26T10:42:00.085ZTruist Securities reiterates Buy on Reddit, PT $275https://stockwhiz.ai/news/costamare-inc-sets-the-date-for-its-third-quarter-2026-results-release-3be14dd7Stockwhizen2026-10-26T10:41:40.114ZCostamare Inc. Sets The Date For Its Third Quarter 2026 Results Releasehttps://stockwhiz.ai/analyst-ratings/advance-auto-parts-inc-rothschild-redburn-sell-pt-32-60c655ddStockwhizen2026-10-26T10:39:29.821ZRothschild Redburn downgrades Advance Auto Parts from Neutral to Sell, cuts PT to $32 from $45https://stockwhiz.ai/analyst-ratings/tesla-inc-barclays-overweight-pt-450-66e9b0f5Stockwhizen2026-10-26T10:38:36.042ZBarclays upgrades Tesla from Equalweight to Overweight, raises PT to $450 from $370https://stockwhiz.ai/analyst-ratings/space-exploration-technologies-corp-bernstein-socgen-group-outperform-pt-268-4b3a539fStockwhizen2026-10-26T10:37:20.077ZBernstein SocGen Group maintains Outperform on SpaceX, raises PT to $268 from $248https://stockwhiz.ai/analyst-ratings/oklo-inc-td-cowen-hold-pt-26-8d5cf2c8Stockwhizen2026-10-26T10:36:16.720ZTD Cowen initiates Hold on Oklo Inc, PT $26https://stockwhiz.ai/analyst-ratings/bloom-energy-corp-wells-fargo-equal-weight-pt-182-da964422Stockwhizen2026-10-26T10:34:54.049ZWells Fargo maintains Equal Weight on Bloom Energy Corp., raises PT to $182 from $176https://stockwhiz.ai/news/vertiv-completes-acquisition-of-king-environmental-services-ltd-expand-05ba83fcStockwhizen2026-10-26T10:30:00.828ZVertiv Completes Acquisition of King Environmental Services Ltd., Expanding Global Fluid Management Serviceshttps://stockwhiz.ai/news/easterly-government-properties-reports-third-quarter-2026-results-5098078bStockwhizen2026-10-26T10:30:00.314ZEasterly Government Properties Reports Third Quarter 2026 Resultshttps://stockwhiz.ai/news/lithium-argentina-announces-repurchase-of-200-million-of-its-2027-conv-e099f552Stockwhizen2026-10-26T10:30:00.281ZLithium Argentina Announces Repurchase of $200 Million of its 2027 Convertible Noteshttps://stockwhiz.ai/news/babcock-wilcox-sets-third-quarter-2026-conference-call-and-webcast-for-6575abe8Stockwhizen2026-10-26T10:30:00.225ZBabcock & Wilcox Sets Third Quarter 2026 Conference Call and Webcast for Monday, November 9, 2026 at 5 p.m. EThttps://stockwhiz.ai/news/kkr-appoints-brian-j-lee-to-board-ba2d1690Stockwhizen2026-10-26T10:30:00.148ZKKR Appoints Brian J. Lee to Boardhttps://stockwhiz.ai/news/casey-s-all-new-pan-pizza-is-now-closer-to-home-for-millions-across-ca-9888a9c4Stockwhizen2026-10-26T10:30:00.111ZCasey’s All-New Pan Pizza Is Now Closer to Home for Millions Across Casey’s Countryhttps://stockwhiz.ai/news/ducommun-to-participate-in-baird-s-global-industrial-conference-e0181e84Stockwhizen2026-10-26T10:30:00.091ZDucommun to Participate in Baird’s Global Industrial Conferencehttps://stockwhiz.ai/news/comstock-inc-to-host-q3-2026-earnings-call-and-business-update-c21842b9Stockwhizen2026-10-26T10:15:00.094ZComstock Inc. to Host Q3 2026 Earnings Call and Business Updatehttps://stockwhiz.ai/news/seagate-simplifies-high-capacity-storage-scaling-for-ai-and-cloud-infr-65ae956fStockwhizen2026-10-26T10:01:00.165ZSeagate Simplifies High-Capacity Storage Scaling for AI and Cloud Infrastructurehttps://stockwhiz.ai/news/globa-terra-acquisition-corporation-announces-revised-shareholder-exte-f06feb55Stockwhizen2026-10-26T10:00:03.983ZGloba Terra Acquisition Corporation Announces Revised Shareholder Extension Proposal, including $0.03 Per Share Payment for Redeeming and Non-Redeeming Shareholders Subject to Extension Approval and Fundinghttps://stockwhiz.ai/news/eqt-announces-strategic-acquisition-of-range-resources-creating-americ-3d4376e0Stockwhizen2026-10-26T10:00:02.644ZEQT Announces Strategic Acquisition of Range Resources, Creating America&#x27;s Undisputed Natural Gas Championhttps://stockwhiz.ai/news/corxel-us-and-amanat-acquisition-corp-announce-definitive-business-com-a199e7fdStockwhizen2026-10-26T10:00:00.303ZCorxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Companyhttps://stockwhiz.ai/news/eikon-therapeutics-presents-updated-eik1001-data-from-teluride-005-at--e9f84a9cStockwhizen2026-10-26T10:00:00.248ZEikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congresshttps://stockwhiz.ai/news/sable-offshore-corp-announces-third-quarter-2026-earnings-release-date-5db1577dStockwhizen2026-10-26T10:00:00.178ZSable Offshore Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Callhttps://stockwhiz.ai/news/leading-independent-proxy-advisory-firm-glass-lewis-recommends-ethan-a-47097772Stockwhizen2026-10-26T10:00:00.151ZLeading Independent Proxy Advisory Firm Glass Lewis Recommends Ethan Allen Shareholders Vote the WHITE Proxy Card “FOR” All Five of Doug Bergeron’s Director Nomineeshttps://stockwhiz.ai/news/tutor-perini-announces-conference-call-to-discuss-third-quarter-2026-r-1af8195cStockwhizen2026-10-26T10:00:00.110ZTutor Perini Announces Conference Call to Discuss Third Quarter 2026 Resultshttps://stockwhiz.ai/news/psnl-merger-investigation-bfa-law-reminds-personalis-shareholders-of-i-51e01edeStockwhizen2026-10-26T09:46:00.423Z$PSNL Merger Investigation: BFA Law Reminds Personalis Shareholders of Its Ongoing Investigation into the $16.25 per Share Merger Dealhttps://stockwhiz.ai/news/pag-merger-investigation-bfa-law-reminds-penske-automotive-group-share-b885d228Stockwhizen2026-10-26T09:46:00.183Z$PAG Merger Investigation: BFA Law Reminds Penske Automotive Group Shareholders of Its Ongoing Investigation into the $212.00 per Share Take-Private Mergerhttps://stockwhiz.ai/news/dhi-group-inc-to-report-third-quarter-financial-results-on-november-4--d58f90bfStockwhizen2026-10-26T09:30:00.132ZDHI Group, Inc. to Report Third Quarter Financial Results on November 4, 2026https://stockwhiz.ai/news/conow-launches-award-winning-atlas-6000-ac-in-germany-advancing-ai-dri-ee81427cStockwhizen2026-10-26T09:00:00.209ZConow Launches Award-Winning Atlas 6000 AC in Germany, Advancing AI-Driven Home Energy Managementhttps://stockwhiz.ai/news/northern-trust-reappointed-by-people-x27-s-pension-49ff4491Stockwhizen2026-10-26T09:00:00.103ZNorthern Trust Reappointed by People&#x27;s Pensionhttps://stockwhiz.ai/news/biontech-and-dualitybio-announce-topline-results-of-the-dynasty-breast-2e8b9e10Stockwhizen2026-10-26T09:00:00.099ZBioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancerhttps://stockwhiz.ai/news/volkswagen-group-strengthens-its-strategic-semiconductor-ecosystem-thr-9714e549Stockwhizen2026-10-26T09:00:00.088ZVolkswagen Group strengthens its strategic semiconductor ecosystem through partnership with NXPhttps://stockwhiz.ai/news/premialab-extends-qis-coverage-to-digital-assets-with-marex-x27-s-inst-44236688Stockwhizen2026-10-26T09:00:00.047ZPremialab Extends QIS Coverage to Digital Assets with Marex&#x27;s Institutional Crypto Indiceshttps://stockwhiz.ai/news/dover-commences-offers-to-purchase-for-cash-certain-of-its-outstanding-7868f03dStockwhizen2026-10-26T08:45:54.161ZDover Commences Offers to Purchase for Cash Certain of Its Outstanding Debt Securitieshttps://stockwhiz.ai/news/elbit-systems-awarded-approximately-200-million-in-contracts-for-airbo-de1bb440Stockwhizen2026-10-26T08:04:18.141ZElbit Systems Awarded Approximately $200 Million in Contracts for Airborne ISTAR and Training Solutions in Asia-Pacifichttps://stockwhiz.ai/news/docusign-intelligent-agreement-management-to-be-sold-as-sap-solution-e-2e9deae5Stockwhizen2026-10-26T08:00:04.450ZDocusign Intelligent Agreement Management to Be Sold as SAP Solution Extensionshttps://stockwhiz.ai/news/cognizant-and-ebrd-partner-to-accelerate-digital-transformation-throug-3134bc70Stockwhizen2026-10-26T08:00:01.663ZCognizant and EBRD Partner to Accelerate Digital Transformation Through AI-Led, Outcome-Driven Serviceshttps://stockwhiz.ai/news/111-inc-announces-appointment-of-independent-financial-advisor-and-leg-7e4bdd2cStockwhizen2026-10-26T08:00:00.656Z111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committeehttps://stockwhiz.ai/news/fti-consulting-adds-bj-rn-storim-to-strengthen-banking-and-capital-mar-7743816cStockwhizen2026-10-26T08:00:00.133ZFTI Consulting Adds Björn Storim to Strengthen Banking and Capital Markets Advisory in Germanyhttps://stockwhiz.ai/news/phathom-pharmaceuticals-provides-update-on-fda-litigation-ed42568fStockwhizen2026-10-26T08:00:00.113ZPhathom Pharmaceuticals Provides Update on FDA Litigationhttps://stockwhiz.ai/news/honeywell-technologies-launches-forge-plant-cognition-with-dangote-bui-8f0be85cStockwhizen2026-10-26T08:00:00.112ZHoneywell Technologies Launches Forge Plant Cognition with Dangote, Built with NVIDIA AI and Dell Technologies Capabilitieshttps://stockwhiz.ai/news/borr-drilling-limited-prospector-5-rig-incident-update-679383e6Stockwhizen2026-10-26T07:57:16.267ZBorr Drilling Limited - Prospector 5 Rig Incident Updatehttps://stockwhiz.ai/news/izalontamab-brengitecan-iza-bren-doubles-median-progression-free-survi-5de112e7Stockwhizen2026-10-26T07:30:00.094ZIzalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cancer Compared to Chemotherapy in the Phase 3 PANKU-Lung01 Studyhttps://stockwhiz.ai/news/reg-bank-of-america-corporation-notification-of-filing-of-documents-e7766f6eStockwhizen2026-10-26T07:00:23.038ZREG-Bank of America Corporation: Notification of Filing of Documentshttps://stockwhiz.ai/news/stmicroelectronics-introduces-first-automotive-safety-combination-sens-b8928be6Stockwhizen2026-10-26T07:00:00.380ZSTMicroelectronics introduces first automotive safety combination sensors for mass-market applicationshttps://stockwhiz.ai/news/reg-tiaa-cref-form-8-3-5c388993Stockwhizen2026-10-26T07:00:00.319ZREG-TIAA-CREF Form 8.3https://stockwhiz.ai/news/zimmer-biomet-india-launches-rosa-knee-with-optimize-in-india-to-advan-e306af55Stockwhizen2026-10-26T06:52:57.755ZZimmer Biomet India Launches ROSA® Knee with OptimiZe™ in India to Advance Personalized Robotic-Assisted Knee Replacementhttps://stockwhiz.ai/news/results-for-first-quarter-ended-august-31-2026-644d6b44Stockwhizen2026-10-26T06:00:21.718ZResults for First Quarter Ended August 31, 2026https://stockwhiz.ai/news/agoda-and-busan-report-growth-in-first-time-and-repeat-visitors-in-fir-7e9c7520Stockwhizen2026-10-26T04:04:03.707ZAgoda and Busan Report Growth in First-Time and Repeat Visitors in First Year of Partnershiphttps://stockwhiz.ai/news/l-t-technology-services-and-nokia-forge-engineering-collaboration-d3f85e3fStockwhizen2026-10-26T03:45:00.095ZL&T Technology Services and Nokia Forge Engineering Collaborationhttps://stockwhiz.ai/news/nasdaq-strengthens-asia-pacific-leadership-team-7c9f8855Stockwhizen2026-10-26T01:00:00.089ZNasdaq Strengthens Asia-Pacific Leadership Teamhttps://stockwhiz.ai/news/ffr-to-hold-listing-ceremony-and-investor-day-on-october-26-ffai-annou-29e69d18Stockwhizen2026-10-26T00:49:13.044ZFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia&#x27;s Investor Weekly Report to October 26https://stockwhiz.ai/news/openworld-confirms-dual-listing-on-figure-open-on-track-for-q4-2026-fo-7e1f6d14Stockwhizen2026-10-26T00:00:00.104ZOpenWorld Confirms Dual Listing on Figure OPEN on Track for Q4 2026 Following Stockholder Approval of Blockchain Common Stockhttps://stockwhiz.ai/news/faraday-future-announces-yt-jia-s-investor-weekly-report-rescheduled-t-27b5f3c5Stockwhizen2026-10-25T23:56:00.086ZFaraday Future Announces YT Jia’s Investor Weekly Report Rescheduled to October 26; FFR to Hold Listing Ceremony and Investor Day on October 26https://stockwhiz.ai/news/didi-shareholders-overwhelmingly-back-hong-kong-relisting-want-indepen-2fa64b55Stockwhizen2026-10-25T23:00:00.042ZDiDi Shareholders Overwhelmingly Back Hong Kong Relisting; Want Independent Director, Open Earnings Calls, and First Shareholder Meeting in Four Years, Survey Findshttps://stockwhiz.ai/news/oruka-therapeutics-to-host-conference-call-to-report-week-16-data-for--0f66476cStockwhizen2026-10-25T16:00:00.066ZOruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026https://stockwhiz.ai/news/ivonescimab-plus-chemotherapy-demonstrates-overall-survival-superiorit-2c2d5682Stockwhizen2026-10-25T15:52:00.099ZIvonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in Chinahttps://stockwhiz.ai/news/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-combination-demons-734a2a15Stockwhizen2026-10-25T13:45:00.035ZRYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancerhttps://stockwhiz.ai/news/arrivent-announces-initial-phase-1-data-for-cdh17-targeted-adc-arr-217-2f28205cStockwhizen2026-10-25T13:00:00.069ZArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026https://stockwhiz.ai/news/amarin-provides-update-on-university-of-leeds-sponsored-phase-3-epa-fo-4644fdc3Stockwhizen2026-10-25T12:11:03.092ZAmarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM)https://stockwhiz.ai/news/agenus-reports-72-of-patients-with-locally-advanced-dmmr-colon-cancer--92e638f7Stockwhizen2026-10-25T11:00:00.157ZAgenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026https://stockwhiz.ai/news/genmab-announces-updated-follow-up-analyses-from-phase-2-study-of-peto-00722a2bStockwhizen2026-10-25T11:00:00.108ZGenmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/novabridge-biosciences-reports-mature-phase-1b-data-at-esmo-2026-posit-2100a9fcStockwhizen2026-10-25T10:59:59.983ZNovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Developmenthttps://stockwhiz.ai/news/reg-genmab-announces-updated-follow-up-analyses-from-phase-2-study-of--2af3bbefStockwhizen2026-10-25T10:59:59.925ZREG-Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancerhttps://stockwhiz.ai/news/libtayo-cemiplimab-longer-term-data-show-increasing-and-clinically-mea-1f0ef50bStockwhizen2026-10-25T09:14:59.964ZLibtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)https://stockwhiz.ai/news/xencor-presents-phase-1-dose-selection-data-for-xmab819-a-potential-fi-057f3dfeStockwhizen2026-10-25T08:35:00.091ZXencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumorshttps://stockwhiz.ai/news/johnson-johnson-reports-75-tumor-response-rate-in-advanced-prostate-ca-697e2d28Stockwhizen2026-10-25T07:30:00.225ZJohnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ moleculehttps://stockwhiz.ai/news/new-data-on-lilly-x27-s-investigational-treatment-olomorasib-at-esmo-2-6346b1ffStockwhizen2026-10-25T07:30:00.027ZNew data on Lilly&#x27;s investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancerhttps://stockwhiz.ai/news/biontech-and-bristol-myers-squibb-report-encouraging-global-phase-2-da-1fcc7824Stockwhizen2026-10-25T07:29:59.860ZBioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapyhttps://stockwhiz.ai/news/borr-drilling-limited-prospector-5-rig-incident-5a806164Stockwhizen2026-10-25T06:08:39.160ZBorr Drilling Limited - Prospector 5 Rig Incidenthttps://stockwhiz.ai/news/climb-bio-presents-initial-prismn-phase-2-data-from-budoprutug-in-pmn--1dbd7428Stockwhizen2026-10-24T23:29:59.912ZClimb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026https://stockwhiz.ai/news/axon-announces-body-5-next-generation-camera-built-for-the-ai-era-8e7721baStockwhizen2026-10-24T17:00:00.043ZAxon Announces Body 5: Next-Generation Camera Built for the AI Erahttps://stockwhiz.ai/news/pfizer-x27-s-25-valent-pediatric-pneumococcal-conjugate-vaccine-candid-0fe5872bStockwhizen2026-10-24T15:18:00.145ZPfizer&#x27;s 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026https://stockwhiz.ai/news/from-private-credit-to-fusion-power-new-to-the-street-show-777-premier-c8837552Stockwhizen2026-10-24T14:31:20.370ZFrom Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Televisionhttps://stockwhiz.ai/news/imdelltra-in-combination-with-imfinzi-reduced-risk-of-death-by-an-unpr-1bf87700Stockwhizen2026-10-24T14:30:00.036ZIMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCERhttps://stockwhiz.ai/news/johnson-johnson-announces-erleada-apalutamide-treatment-before-and-aft-94c5dbdaStockwhizen2026-10-24T12:55:08.680ZJohnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancerhttps://stockwhiz.ai/news/parabilis-medicines-presents-updated-phase-1-2-data-for-zolucatetide-d-b2988ad6Stockwhizen2026-10-24T12:44:59.340ZParabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors